BNBX · Bnb Plus Corp.
$0.13
+0.00 (+0.00%)
At close · Aug 7
Market Cap
$935,639
Shares
7.20M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| James A. Hayward | CEO | $773,461 |
| Judith Murrah | CEO | $754,654 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| James A. Hayward | CEO | $387,623 |
| Beth Jantzen | CFO | $300,000 |
| Clay Shorrock | Board Member | $300,000 |
| Judith Murrah | CEO | $292,055 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Judith Murrah | COO | $542,750 |
| Beth Jantzen | CFO | $501,000 |
| Clay Shorrock | Board Member | $501,000 |
| Dr. James Hayward | CEO | $468,000 |
| James A. Hayward | CEO | $468,000 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dr. James Hayward | CEO | $2,068,000 |
| James A. Hayward | CEO | $2,068,000 |
| Judith Murrah | COO | $580,125 |
| Beth Jantzen | CFO | $535,500 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James A. Hayward | CEO | $1,454,832 |
| Judith Murrah | COO | $402,122 |
| Beth Jantzen | CFO | $366,545 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Patrick Horsman | Chief Investment Officer | Terminated | 2026-07-29 |
| Joshua Kruger | director | Resigned | 2026-07-29 |
| Joshua Kruger | Chairman | Resigned | 2026-07-29 |
| James Haft | director | Appointed | 2026-02-05 |
| Elizabeth M. Schmalz Shaheen | director | Resigned | 2026-01-22 |
| Judith Murrah | Chairperson of the Board | Resigned | 2025-11-10 |
| Joshua Kruger | director | Appointed | 2025-11-10 |
| Joshua Kruger | Chairman and as a director | Appointed | 2025-11-10 |
| Judith Murrah | member of the Board | Appointed | 2025-06-17 |
| Judith Murrah | Chairperson | Appointed | 2025-06-17 |
| Judith Murrah | Chief Executive Officer | Appointed | 2025-06-17 |
| Dr. James A. Hayward | Chairman of the Board | Retired | 2025-06-17 |
| Dr. James A. Hayward | member of the Company's board of directors | Retired | 2025-06-17 |
| Dr. James A. Hayward | Chief Executive Officer | Retired | 2025-06-17 |
| Clay Shorrock | President of LineaRx | Appointed | 2024-12-17 |
| James Hayward | President | Resigned | 2024-12-17 |
| Judith Murrah | President of the Company | Appointed | 2024-12-17 |